RetaMaps

Mountainside Medical Group - Primary Care

Mountainside Medical Group - Primary Care · 311 Bay Avenue · Glen Ridge, NJ 07028

4.6· 117 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

About this practice

Mountainside Medical Group - Primary Care is a primary care practice in Glen Ridge, New Jersey, whose listed website is that of Mountainside Medical Center. That site mentions board-certified family physicians providing convenient care and an Adult Health Center offering vaccinations, screenings and chronic disease management, and notes weight-loss seminars at the medical center. On Google the practice has a 4.6-star rating across 117 reviews, which began in 2024, with 72 in the past year; staff (15), knowledge (12) and a caring manner (9) come up most.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.6
Google rating · 117 reviews
72
reviews in the past year (avg ★ 4.7)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-28. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.6 across 117 Google reviews. Of the 100 reviews we analyzed, 94 (94%) are positive (4–5★) and 5 (5%) are negative (1–2★).

What patients like

  • Friendly, helpful staff12 reviews
  • Knowledgeable, professional providers11 reviews
  • Feeling listened to11 reviews
  • Short waits, on-time visits3 reviews

Common complaints

  • Staff or front-desk issues3 of 5 negative
  • Billing, pricing or insurance problems2 of 5 negative
  • Scheduling or communication problems2 of 5 negative
5★
89
4★
5
3★
1
2★
0
1★
5

Most recent Google reviews

Terry M.★★★★★2026-09-28

Always treated kindly. Visits go smoothly

Eileen p.★★★★★2026-09-21

Love the staff they are so nice and Dr galini is super he actually listens when you come to see him

MalindaJane P.★★★★★2026-09-17

Everyone is Friendly and Professional A+!

ADRIAN C.★★★★★2026-09-14

Dr Molinaro is a wonderful doctor

Sandhya K.★★★★★2026-09-06

Great doctors, and great carr

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Glen Ridge

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs